Document is current
Any future updates will be listed below
-
Authors
Holmberg-Thydén, Staffan https://orcid.org/0000-0001-5357-0646
Dufva, Inge Høgh
Gang, Anne Ortved
Breinholt, Marie Fredslund
Schejbel, Lone
Andersen, Mette Klarskov
Kadivar, Mohammad
Svane, Inge Marie
Grønbæk, Kirsten
Hadrup, Sine Reker
El Fassi, Daniel https://orcid.org/0000-0001-8226-1658
-
Funding
Funding for this research was provided by:
Kræftens Bekæmpelse (R72-A4531)
Kræftens Bekæmpelse (R146-A9531-16-S2)
Herlev Hospital
Celgene (Unrestricted research grant)
- License Information
-
More Information
Article History
Received: 5 December 2020
Accepted: 19 June 2021
First Online: 4 July 2021
Declaration
:
: Celgene provided an unrestricted research grant for this clinical trial. They were allowed to read the final manuscript prior to publication but did not have any influence on the planning, conduction, or publishing of this clinical trial. There were no other conflicts of interest to report.
: The study was conducted in accordance with the Helsinki Declaration and ICH-GCP, and approved by the Danish Medicines Agency and the regional research ethics committee in Denmark. The trial is registered in the EU Clinical Trials Register (2014–002432-14) and clinicaltrials.gov (NCT02750995).
: Written informed consent was obtained from all patients in the clinical trial following oral and written information.
: All patients consented to the publication of anonymized data in scientific journals prior to receiving written and oral information hereof.
